JAGSNPHARM Jagsonpal Pharmaceuticals Ltd Earnings Reports Announcement 2025 - Q3 Earnings Update Jagsonpal Pharmaceuticals reported Q3 FY25 revenues of INR 210 crores, up 27%, and net profit of INR 31.6 crores, a 67% increase, showing strong operational performance and a cash balance increase to INR 132 crores..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Jagsonpal Pharmaceuticals Ltd